3878

TOMOEGAWA CORPORATION

巴川コーポレーション

Industry
Chemicals
Market
Standard
Accounting standards
Japanese GAAP
Consolidation basis
Consolidated

Key metrics

Revenue(million JPY)

Mar 2021
30,768
Mar 2022
32,785
Mar 2023
34,170
Mar 2024
33,692
Mar 2025
34,432

Operating profit(million JPY)

Mar 2021
-15
Mar 2022
1,982
Mar 2023
2,052
Mar 2024
1,331
Mar 2025
1,282

Operating profit margin(%)

Mar 2021
-0.05
Mar 2022
6.05
Mar 2023
6.01
Mar 2024
3.95
Mar 2025
3.72

Profit before tax(million JPY)

Mar 2021
-628
Mar 2022
2,537
Mar 2023
2,377
Mar 2024
1,363
Mar 2025
1,396

Profit(million JPY)

Mar 2021
-1,152
Mar 2022
1,650
Mar 2023
1,451
Mar 2024
594
Mar 2025
749

Total assets(million JPY)

Mar 2021
40,658
Mar 2022
43,574
Mar 2023
42,948
Mar 2024
45,713
Mar 2025
46,087

Cash and cash equivalents(million JPY)

Mar 2021
3,988
Mar 2022
4,737
Mar 2023
4,282
Mar 2024
5,345
Mar 2025
4,853

Cash flows from operating activities(million JPY)

Mar 2021
4,213
Mar 2022
3,364
Mar 2023
1,010
Mar 2024
4,185
Mar 2025
1,799

Cash flows from investing activities(million JPY)

Mar 2021
-1,305
Mar 2022
-217
Mar 2023
-54
Mar 2024
-1,741
Mar 2025
-2,758

Cash flows from financing activities(million JPY)

Mar 2021
-2,423
Mar 2022
-2,651
Mar 2023
-1,566
Mar 2024
-1,645
Mar 2025
500

Return on equity(%)

Mar 2021
-11.2
Mar 2022
13.2
Mar 2023
10.6
Mar 2024
4.1
Mar 2025
5

Equity ratio(%)

Mar 2021
28.3
Mar 2022
30.9
Mar 2023
32.7
Mar 2024
32.2
Mar 2025
33.1

Earnings per share(JPY per share)

Mar 2021
-114.84
Mar 2022
152.71
Mar 2023
135.11
Mar 2024
57.28
Mar 2025
73.05

Net assets per share(JPY per share)

Mar 2021
940.17
Mar 2022
1,113.45
Mar 2023
1,251.36
Mar 2024
1,417.49
Mar 2025
1,511.71

Dividend per share(JPY per share)

Mar 2021
-
Mar 2022
15
Mar 2023
15
Mar 2024
15
Mar 2025
15

Payout ratio(%)

Mar 2021
-
Mar 2022
9.82
Mar 2023
11.1
Mar 2024
26.19
Mar 2025
20.53

Disclaimer

The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.

The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.